早期がん発症に対するリスク因子の影響
Clare E Weeden1, William Hill1, Emilia L Lim2
1Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
Cell
|April 14, 2023
まとめ
癌の発症は複雑で 早期の細胞はさらなる成長から守られています 非変異性経路の理解は 分子がんの予防と早期治療の鍵です
科学分野:
- 腫瘍学
- 細胞生物学
- 癌 の 予防
背景:
- 腫瘍形成は以前考えられていたより複雑で 腫瘍細胞は健康な組織と 解剖で発見されるのがんです
- 人体 の 複雑 な 細胞 組織 は,悪性 細胞 の 増殖 に 対し て 堅固 な 防御 機構 を 必要 と し て い ます.
- 細胞レベルで がんが滅多に発生しない理由を理解することは 効果的な予防戦略の開発に不可欠です
研究 の 目的:
- 早期発症した細胞がさらなる腫瘍形成からどのように保護されているかを検討する.
- 癌のリスク因子が腫瘍の成長を促す非変異性経路について議論する.
- 早期がん検知と 分子予防の戦略を探求する.
主な方法:
- 腫瘍発症とがん予防に関する現在の研究の文献レビュー.
- 癌のリスク因子の促進に関与する非変異性経路の分析
- 既存の早期がん検知戦略の評価
主要な成果:
- 早期発現した細胞は,さらなる腫瘍形成に対して 防御的メカニズムを持っています.
- 非変異性経路は 腫瘍の成長に寄与する 遺伝的変異だけではありません
- いくつかの腫瘍促進メカニズムに恒久的なゲノム変化がないことは 治療目標を提供している.
結論:
- 非変異性経路をターゲットにすることで 分子がんの予防に良い機会が生まれます
- 早期の検知戦略は 癌の発生を防ぐために不可欠です
- 細胞の防御メカニズムに関するさらなる研究は 新しい予防療法につながる可能性があります
さらに関連する動画
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
312
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
11.6K
関連する概念動画
Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
Cancers Originate from Somatic Mutations in a Single Cell
12.3K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.3K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Cancer Survival Analysis
406
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
406
Cancer
49.0K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
49.0K
